J Korean Soc Pediatr Endocrinol.
2007 Jun;12(1):87-89.
Pamidronate Treatment in Vertebral Fracture after Off-therapy of Medulloblastoma
- Affiliations
-
- 1Department of Pediatrics, Korean Cancer Center Hospital. Seoul, Korea. limjs@kcch.re.kr
Abstract
- A twenty-one year old man, who had been treated for medulloblastoma 6 years ago, complained progressive right knee joints pain and back pain. Multiple thoracic vertebral compression fracture was detected in radiography. The bone mineral density(BMD) was in osteoporotic range in duel energy X-ray absorpometry. Growth hormone deficiency and primary hypothyroidism were detected after endocrine function test. We treated him by cyclic intravenous pamidronate because he had complained severe back pain and difficulty to walk. After pamidronate therapy, the pain was decreased and the BMD was increased. No severe adverse effect was noted. This is the first case report of pamidronate therapy in patient who had osteoporotic vertebral compression fracture due to a sequela of childhood medulloblastoma.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effectiveness and safety of pamidronate treatment in nonambulatory children with low bone mineral density
- Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
- Molecular Pathologic Classification of Medulloblastoma
- Efficacy of Cyclic Intravenous Pamidronate Therapy for Children with Osteogenesis Imperfecta
- Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
